Explore the categories so you can find more about your search.

Categorie > Lupus

Molecule Linked To Autoimmune Disease Relapses Identified At Stanford

Categorie : Lupus
The ebb and flow of such autoimmune diseases as multiple sclerosis, lupus and rheumatoid arthritis has long been a perplexing mystery. But new findings from the Stanford University School of Medicine bring scientists closer to solving the puzzle, identifying a molecule that appears to play a central ...

read more The ebb and flow of such autoimmune diseases as multiple sclerosis, lupus and rheumatoid arthritis has long been a perplexing mystery. But new findings from the Stanford University School of Medicine bring scientists closer to solving the puzzle, identifying a molecule that appears to play a central read more Thu Dec 2006 Thu Dec 2006

High-Tech Spectroscopy May Be Used To Monitor Neuropsychiatric Symptoms

Categorie : Lupus
Magnetic resonance spectroscopy (MRS) may provide a noninvasive way to monitor neuropsychiatric symptoms in patients with lupus, according to results from research in mice at Wake Forest University School of Medicine."This study is the first to demonstrate that MRS is a feasible method to monitor ne ...

read more Magnetic resonance spectroscopy (MRS) may provide a noninvasive way to monitor neuropsychiatric symptoms in patients with lupus, according to results from research in mice at Wake Forest University School of Medicine. read more Wed Nov 2006 Wed Nov 2006

New Biomarkers For Lupus Found

Categorie : Lupus
A Wake Forest University School of Medicine team believes it has found biomarkers for lupus that also may play a role in causing the disease.The biomarkers are micro-ribonucleic acids (micro-RNAs), said Nilamadhab Mishra, M.D. He and colleagues reported at the American College of Rheumatology meetin ...

read more A Wake Forest University School of Medicine team believes it has found biomarkers for lupus that also may play a role in causing the disease.The biomarkers are micro-ribonucleic acids (micro-RNAs), said Nilamadhab Mishra, M.D. He and colleagues reported at the American College of Rheumatology meetin read more Tue Nov 2006 Tue Nov 2006

La Jolla Limited Withdraws Its Marketing Authorisation Application For Riquent To Treat Lupus Nuphritis

Categorie : Lupus
The European Medicines Agency has been formally notified by La Jolla Limited of its decision to withdraw its application for a centralised marketing authorisation for the medicinal product Riquent (abetimus sodium).Riquent was expected to be used to treat lupus nephritis, an inflammation of the kidn ...

read more The European Medicines Agency has been formally notified by La Jolla Limited of its decision to withdraw its application for a centralised marketing authorisation for the medicinal product Riquent (abetimus sodium).Riquent was expected to be used to treat lupus nephritis, an inflammation of the kidn read more Thu Oct 2006 Thu Oct 2006

Spleen Cells May Prove Effective Target for Lupus Treatment (HealthDay)

Categorie : Lupus
Research done on mice specially bred to develop lupus has uncovered an area of the spleen that may give rise to the disease. ...

read more Research done on mice specially bred to develop lupus has uncovered an area of the spleen that may give rise to the disease. read more Tue Sep 2006 Tue Sep 2006

HIV/AIDS Therapy Still Effective 10 Years On (HealthDay)

Categorie : Lupus
Ten years after it was introduced, highly active antiretroviral therapy (HAART) remains very effective at lowering the risk of AIDS and death in people with HIV, a study in this week's issue of The Lancet finds. ...

read more Ten years after it was introduced, highly active antiretroviral therapy (HAART) remains very effective at lowering the risk of AIDS and death in people with HIV, a study in this week's issue of The Lancet finds. read more Tue Sep 2006 Tue Sep 2006

Stem Cells Transformed Into Immune Cells (HealthDay)

Categorie : Lupus
New research into embryonic stem cells suggests great potential for medical advances but also confirms that big breakthroughs aren't waiting just around the corner. ...

read more New research into embryonic stem cells suggests great potential for medical advances but also confirms that big breakthroughs aren't waiting just around the corner. read more Tue Sep 2006 Tue Sep 2006

Lupus News from Medical News Today

Categorie : Lupus
Latest Lupus news updated throughout the day, every day ...

read more Latest Lupus news updated throughout the day, every day read more Tue Aug 2006 Tue Aug 2006

Biomarkers Could Drive Arthritis Research (HealthDay)

Categorie : Lupus
An international team of scientists has identified new biomarkers that could help develop improved treatments for spondylarthritis (SpA). ...

read more An international team of scientists has identified new biomarkers that could help develop improved treatments for spondylarthritis (SpA). read more Tue Aug 2006 Tue Aug 2006

Cell Therapy Might Boost Babies' Immune Response (HealthDay)

Categorie : Lupus
Spanish ID:532366--> ...

read more Spanish ID:532366--> read more Tue Aug 2006 Tue Aug 2006

Warmer Weather Brings Wheezing, Sneezing (HealthDay)

Categorie : Lupus
April showers bring -- the beginning of another allergic asthma season, experts say. ...

read more April showers bring -- the beginning of another allergic asthma season, experts say. read more Tue Aug 2006 Tue Aug 2006

Two Pivotal Phase III Trials In Lupus, Immunomedics

Categorie : Lupus
Immunomedics Inc announced patient dosing has begun for the pivotal Phase III clinical trials to further evaluate the safety and efficacy of the Company's lead drug candidate, epratuzumab, for the treatment of patients with systemic lupus erythematosus (SLE), known as lupus. Epratuzumab has been ...

read more Immunomedics Inc announced patient dosing has begun for the pivotal Phase III clinical trials to further evaluate the safety and efficacy of the Company's lead drug candidate, epratuzumab, for the treatment of patients with systemic lupus erythematosus (SLE), known as lupus. Epratuzumab has been read more Mon Aug 2006 Mon Aug 2006

A candidate biomarker to improve treatment of lupus patients

Categorie : Lupus
Study associates high expression of interferon induced genes with increased disease severity, including kidney disease - A chronic disease of the immune system, systemic lupus erythematosus (SLE) affects approximately 1.5 million people nationwide, according to the Lupus Foundation of America. [clic ...

read more Study associates high expression of interferon induced genes with increased disease severity, including kidney disease - A chronic disease of the immune system, systemic lupus erythematosus (SLE) affects approximately 1.5 million people nationwide, according to the Lupus Foundation of America. [clic read more Mon Aug 2006 Mon Aug 2006

Lupus and the role of Epstein-Barr virus

Categorie : Lupus
Study suggests a common viral infection may increase risk of lupus in African Americans. Findings also show that genetic variation may affect the immune response to Epstein-Barr virus in lupus patients. Almost everyone has been infected with Epstein-Barr virus (EBV), a member of the herpes family an ...

read more Study suggests a common viral infection may increase risk of lupus in African Americans. Findings also show that genetic variation may affect the immune response to Epstein-Barr virus in lupus patients. Almost everyone has been infected with Epstein-Barr virus (EBV), a member of the herpes family an read more Mon Aug 2006 Mon Aug 2006

Secere Lupus - Immunomedics' Humanized anti-CD20 Antibody Effective

Categorie : Lupus
Immunomedics, Inc (Nasdaq: IMMU) today announced that a patient with severe resistant systemiclupus erythematosus (SLE), including the development of human antichimericantibodies (HACA) against rituximab, responded to the Company's new humanizedanti-CD20 monoclonal antibody. [click link for full art ...

read more Immunomedics, Inc (Nasdaq: IMMU) today announced that a patient with severe resistant systemiclupus erythematosus (SLE), including the development of human antichimericantibodies (HACA) against rituximab, responded to the Company's new humanizedanti-CD20 monoclonal antibody. [click link for full art read more Mon Aug 2006 Mon Aug 2006

Lupus Research Institute increases funding for innovative research

Categorie : Lupus
Committed to its core belief that original thinking--idea-driven science--is the overarching need in lupus research, the Lupus Research Institute (LRI) is raising its individual novel research grant awards to $300,000. "Despite such encouraging progress as biomarker initiatives and hopeful stirring ...

read more Committed to its core belief that original thinking--idea-driven science--is the overarching need in lupus research, the Lupus Research Institute (LRI) is raising its individual novel research grant awards to $300,000. read more Mon Aug 2006 Mon Aug 2006

Despite causes of lupus proving complex, critical 'checkpoint' suggesting new therapy is revealed

Categorie : Lupus
Mouse studies yield cause and potential cure, with human studies in progress - Scientists at The Rockefeller University have determined that the autoimmune disease lupus results from a combination of genetics that likely varies from person to person, and that a common "gatekeeper" gene called FCRgII ...

read more Mouse studies yield cause and potential cure, with human studies in progress - Scientists at The Rockefeller University have determined that the autoimmune disease lupus results from a combination of genetics that likely varies from person to person, and that a common read more Mon Aug 2006 Mon Aug 2006

Researchers identify pathway that jumpstarts the autoimmune response in lupus

Categorie : Lupus
Patients with systemic lupus erythematosus (SLE) produce autoantibodies to their own proteins and DNA and the resultant inflammation can cause kidney damage, arthritis, and inflammation of the heart and blood vessels. [click link for full article] ...

read more Patients with systemic lupus erythematosus (SLE) produce autoantibodies to their own proteins and DNA and the resultant inflammation can cause kidney damage, arthritis, and inflammation of the heart and blood vessels. [click link for full article] read more Mon Aug 2006 Mon Aug 2006

ZymoGenetics Releases Preliminary Findings From Atacicept (TACI-Ig) Phase 1b Studies In Patients With Lupus

Categorie : Lupus
ZymoGenetics, Inc. (Nasdaq:ZGEN) today announced preliminary positive results from two Phase 1bclinical trials in patients with systemic lupus erythematosus (SLE) treatedwith atacicept (formerly referred to as TACI-Ig). The results demonstrateda favorable tolerability profile and indicated biologic ...

read more ZymoGenetics, Inc. (Nasdaq:ZGEN) today announced preliminary positive results from two Phase 1bclinical trials in patients with systemic lupus erythematosus (SLE) treatedwith atacicept (formerly referred to as TACI-Ig). The results demonstrateda favorable tolerability profile and indicated biologic read more Mon Aug 2006 Mon Aug 2006

Human Genome Sciences Announces Full Presentation Of Results Of Phase 2 Clinical Trial Of LymphoStat-B(TM) In Systemic Lupus Erythematosus

Categorie : Lupus
Human GenomeSciences, Inc. (Nasdaq: HGSI) announced today that a Phase 2 clinical trialdemonstrated that LymphoStat-B(TM) (belimumab) significantly reduceddisease activity in patients with serologically active systemic lupuserythematosus (SLE), exhibited clinically relevant bioactivity, and wassafe ...

read more Human GenomeSciences, Inc. (Nasdaq: HGSI) announced today that a Phase 2 clinical trialdemonstrated that LymphoStat-B(TM) (belimumab) significantly reduceddisease activity in patients with serologically active systemic lupuserythematosus (SLE), exhibited clinically relevant bioactivity, and wassafe read more Mon Aug 2006 Mon Aug 2006

<<< previous | 1 | 2 | 3 | 4 next >>>



     


Custom Search